2024 - Presenting Companies
Genome Opinion
Profile
Genome Opinion is at the forefront of precision medicine development targeting diseases driven by Clonal Hematopoiesis (CH). Utilizing our proprietary GENO-VERSE database, we employ a strategic methodology to enhance our research and development efforts. Our methodology encompasses:
• Identifying specific patient demographics for targeted therapeutic interventions.
• Discovering or acquiring tailored treatments for these groups.
• Expediting the clinical trial process via early local POC studies.